Roswell Park Cancer Institute | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Director New Product Planning

Morphosys

Click here for more information

Trial results

24 January 2024

OncoC4 takes its Siglec-10 bet into the clinic

The anti-Siglec-10 MAb ONC-841 features among the latest crop of first-in-human trial initiations.

Subscribe to Roswell Park Cancer Institute